“We understand that Competition Commission of India has approved the proposed Fortis-IHH transaction. We remain committed to work towards the seamless closure of the transaction.” Fortis Healthcare said in a statement.

This was the last major approval pending for the deal to be consummated.

In August this year, shareholders of Fortis approved the deal, ending the prolonged uncertainty and bidding war at the hospital chain that faced liquidity crunch and governance issues.

related news

The board of directors of Fortis Healthcare on July 13 unanimously approved a binding investment proposal from IHH to invest Rs 4,000 crore by way of preferential allotment.

The allotment will take place at Rs 170 a share.

Since IHH's post-acquisition stake in Fortis will exceed 25 percent, it is required to extend an offer to buy an additional 26 percent from existing shareholders at a price not less than the one at which the stake is being bought.

After the transaction and the resultant open offer go through, IHH's stake in Fortis could be between 31 to 57 percent, depending on the subscription received for the open offer.

With the CCI approval, IHH will be able to make an open offer for an additional 26 percent stake.

The money infused through the Fortis-IHH deal is expected to meet Fortis' short term and long term cash requirements including acquiring assets from Singapore-based Religare Health Trust and providing an exit to private equity investors in SRL, Fortis' diagnostics arm.

As per the proposal, IHH will have the right to control two-thirds of the seats on the Fortis board.

Fortis plunged into a crisis early this year, with the company disclosing that the promoters took out Rs 500 crore from the company through questionable inter-corporate deposits.

Soon, both the promoters Malvinder and Shivinder, called as Singh brothers resigned, and their stake in the hospital chain pledged with lenders was invoked, on account of non-payment of due.

The Singh brothers' stake in the company has fallen to 0.80 percent from 34.43 percent in February as lenders invoked the shares pledged by them.

Fortis board had to overturn its decisions twice in the face of shareholder activism after announcing Manipal Hospitals group and Munjal-Burman as successful bidders.